Georgia Cancer Center at Augusta University | Strategic Alliance Partners

The Georgia Cancer Center at Augusta University brings together a team of basic science researchers, clinicians, radiation oncologists, nurse navigators and patient support staff to create a community fostering innovation and care focused on improving the lives of our patients. This team approach is focused on patients across the state of Georgia and neighboring states providing access to more first-in-the-nation clinical trials, world-renowned experts and a multidisciplinary approach that keeps the patient at the center of care. Research at the Georgia Cancer Center’s M. Bert Storey Research Building focuses on the most promising pathways for the prevention and treatment of cancer. Several of our researchers are involved with investigator-initiated clinical trials, transitioning their research into the clinic.

Latest from Georgia Cancer Center at Augusta University

Adaptation Is Key to Advancing Care for Adult Patients With Leukemia

December 21, 2021

Article

Jorge E. Cortes, MD, has been an investigative leader for nearly 30 years in the development of numerous leukemia treatments.

Paceline Ride Donates $126,000 to Advance Research Projects at the Georgia Cancer Center

October 08, 2021

Article

The Paceline Ride, LLC team delivered a check for $126,000 to the Georgia Cancer Center at Augusta University.

Augusta University Community Encouraged to Register for Paceline Event in October

October 01, 2021

Article

The Augusta University community is encouraged to participate in this year’s Paceline bicycle ride on October 16.

Dr. Cortes on the Challenges of Using Ruxolitinib in MPNs

April 24, 2020

Video

Jorge E. Cortes, MD, director of the Georgia Cancer Center at Augusta University, discusses the challenges of using ruxolitinib (Jakafi) in patients with myeloproliferative neoplasms (MPNs).

Managing Treatment Toxicity in CML and MPNs

April 14, 2020

Article

Jorge E. Cortes, MD, discusses managing treatment toxicities to optimize therapeutic outcomes in patients with CML and MPNs.

Cortes Underscores Rationale for BCMA-Directed Therapy in Multiple Myeloma

March 19, 2020

Article

Jorge E. Cortes, MD, discusses the evolution of multiple myeloma treatment, the role of BCMA-directed therapies, and remaining questions that need to be addressed in this space

Dr. Cortes on the Advantage of BCMA-Targeted Therapy in Multiple Myeloma

March 19, 2020

Video

Jorge E. Cortes, MD, director of the Georgia Cancer Center at Augusta University, discusses the advantage of BCMA-targeted therapy in multiple myeloma.

Dr. Ghamande on the AIM2CERV Trial in Cervical Cancer

January 13, 2018

Video

Sharad Ghamande, MD, associate professor, Georgia Cancer Center, Augusta University, discusses the AIM2CERV trial for patients with cervical cancer.

Dr. Ghamande Discusses GOG/NRG 0265 Study in Cervical Cancer

November 09, 2017

Video

Sharad Ghamande, MD, associate professor, Georgia Cancer Center, Augusta University, discusses the GOG/NRG-0265 study in cervical cancer.

Therapy Combinations May Become the Treatment of Choice in Ovarian Cancer

July 12, 2017

Article

The future of treatment for ovarian cancer may lie in immunotherapy combinations with PARP inhibitors or checkpoint inhibitors.